Azzad Asset Management Inc. ADV Boosts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Azzad Asset Management Inc. ADV boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,952 shares of the medical equipment provider’s stock after buying an additional 56 shares during the period. Intuitive Surgical accounts for about 0.9% of Azzad Asset Management Inc. ADV’s investment portfolio, making the stock its 13th biggest holding. Azzad Asset Management Inc. ADV’s holdings in Intuitive Surgical were worth $7,564,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of ISRG. Mutual Advisors LLC lifted its holdings in Intuitive Surgical by 27.9% during the third quarter. Mutual Advisors LLC now owns 834 shares of the medical equipment provider’s stock worth $244,000 after buying an additional 182 shares during the period. AQR Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 0.8% during the 3rd quarter. AQR Capital Management LLC now owns 80,283 shares of the medical equipment provider’s stock valued at $23,466,000 after purchasing an additional 628 shares during the last quarter. Truist Financial Corp lifted its holdings in shares of Intuitive Surgical by 25.8% during the 3rd quarter. Truist Financial Corp now owns 250,991 shares of the medical equipment provider’s stock valued at $73,362,000 after purchasing an additional 51,531 shares during the last quarter. Glenmede Trust Co. NA lifted its holdings in shares of Intuitive Surgical by 20.9% during the 3rd quarter. Glenmede Trust Co. NA now owns 56,963 shares of the medical equipment provider’s stock valued at $16,650,000 after purchasing an additional 9,845 shares during the last quarter. Finally, Advisors Asset Management Inc. lifted its holdings in shares of Intuitive Surgical by 2.8% during the 3rd quarter. Advisors Asset Management Inc. now owns 7,649 shares of the medical equipment provider’s stock valued at $2,236,000 after purchasing an additional 205 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently commented on ISRG. Piper Sandler increased their price objective on Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a report on Friday, April 19th. Jefferies Financial Group increased their price objective on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a report on Friday, April 19th. Robert W. Baird decreased their price objective on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a report on Friday, April 19th. Citigroup raised their target price on Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Finally, BTIG Research raised their target price on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Six equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $404.79.

Insider Activity

In other news, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total transaction of $589,484.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, EVP Robert Desantis sold 239 shares of the firm’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $416.60, for a total value of $99,567.40. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,293,799.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction dated Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total transaction of $589,484.00. The disclosure for this sale can be found here. Insiders have sold 17,956 shares of company stock worth $6,927,011 in the last ninety days. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Trading Down 1.3 %

ISRG traded down $5.81 during midday trading on Wednesday, hitting $433.00. 203,652 shares of the company were exchanged, compared to its average volume of 1,514,258. The company’s 50 day simple moving average is $406.41 and its 200 day simple moving average is $385.08. The firm has a market capitalization of $153.59 billion, a price-to-earnings ratio of 78.55, a price-to-earnings-growth ratio of 5.75 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $448.10.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. During the same period last year, the firm earned $1.00 EPS. The company’s quarterly revenue was up 11.5% on a year-over-year basis. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 4.8 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.